ExpertACCA · Question 03 · Strategic Business Reporting
SECTION B
Background:
Ceres AgriCorp is a large-scale commercial farming enterprise specialising in viticulture (wine production). The company owns extensive vineyards.
During the current reporting period, Ceres AgriCorp has faced two significant accounting issues:
Issue 1: Biological Assets
Ceres owns grapevines that have an expected productive life of 40 years. At the reporting date, the vines are bearing a heavy crop of grapes that are two weeks away from harvest. The directors are confused about whether the grapevines and the unharvested grapes should be accounted for under IAS 16 Property, Plant and Equipment or IAS 41 Agriculture, and how changes in fair value should be recognised.
Issue 2: Climate Change and Impairment
Ceres operates a large grape-processing facility. Recently, the region has experienced severe, unprecedented droughts linked to climate change, which are expected to reduce crop yields by 20% over the next decade and increase water procurement costs significantly. The directors are preparing a value-in-use (VIU) calculation to test the processing facility for impairment under IAS 36 Impairment of Assets. They have currently excluded the increased water costs from the cash flow projections, arguing they are 'future restructuring costs'.
Stakeholder Perspective:
Institutional investors have expressed frustration with Ceres AgriCorp's financial statements, noting that the profit or loss figure is highly volatile and makes it difficult to assess the underlying cash-generating performance of the business.
Required:
(a) Advise the directors on the correct accounting treatment for the grapevines and the unharvested grapes under IFRS standards. (8 marks)
(b) Discuss how the climate change risks should be incorporated into the impairment review of the processing facility under IAS 36, and evaluate the directors' decision to exclude the increased water costs. (9 marks)
(c) Explain to the directors why institutional investors might find the fair value accounting of biological assets challenging when interpreting the financial statements, and how investors might adjust their analysis. (8 marks)
SECTION B
Background:
Ceres AgriCorp is a large-scale commercial farming enterprise specialising in viticulture (wine production). The company owns extensive vineyards.
During the current reporting period, Ceres AgriCorp has faced two significant accounting issues:
Issue 1: Biological Assets
Ceres owns grapevines that have an expected productive life of 40 years. At the reporting date, the vines are bearing a heavy crop of grapes that are two weeks away from harvest. The directors are confused about whether the grapevines and the unharvested grapes should be accounted for under IAS 16 Property, Plant and Equipment or IAS 41 Agriculture, and how changes in fair value should be recognised.
Issue 2: Climate Change and Impairment
Ceres operates a large grape-processing facility. Recently, the region has experienced severe, unprecedented droughts linked to climate change, which are expected to reduce crop yields by 20% over the next decade and increase water procurement costs significantly. The directors are preparing a value-in-use (VIU) calculation to test the processing facility for impairment under IAS 36 Impairment of Assets. They have currently excluded the increased water costs from the cash flow projections, arguing they are 'future restructuring costs'.
Stakeholder Perspective:
Institutional investors have expressed frustration with Ceres AgriCorp's financial statements, noting that the profit or loss figure is highly volatile and makes it difficult to assess the underlying cash-generating performance of the business.
Required:
(a) Advise the directors on the correct accounting treatment for the grapevines and the unharvested grapes under IFRS standards. (8 marks)
(b) Discuss how the climate change risks should be incorporated into the impairment review of the processing facility under IAS 36, and evaluate the directors' decision to exclude the increased water costs. (9 marks)
(c) Explain to the directors why institutional investors might find the fair value accounting of biological assets challenging when interpreting the financial statements, and how investors might adjust their analysis. (8 marks)
How to approach this question
Full Answer
Common mistakes
Practice the full ACCA SBR — Strategic Business Reporting Practice Exam 1
4 questions · hints · full answers · grading